Cargando…

Ryzyko przeniesienia czynników zakaźnych przez transfuzje w Polsce

Blood transfusion in Poland is the safest in history. High virological level of safety has been achieved mainly by improving not only the qualification of donors and methods used for donor screening, but also applying leukoreduction, pathogen reduction technology and grace period for serum. In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Grabarczyk, Piotr, Kopacz, Aneta, Sulkowska, Ewa, Kalińska, Aleksandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Polskie Towarzystwo Hematologów i Transfuzjologów, Instytut Hematologii i Transfuzjologii. Published by Elsevier Sp. z o.o. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094117/
https://www.ncbi.nlm.nih.gov/pubmed/32226060
http://dx.doi.org/10.1016/j.achaem.2017.07.006
_version_ 1783510403869835264
author Grabarczyk, Piotr
Kopacz, Aneta
Sulkowska, Ewa
Kalińska, Aleksandra
author_facet Grabarczyk, Piotr
Kopacz, Aneta
Sulkowska, Ewa
Kalińska, Aleksandra
author_sort Grabarczyk, Piotr
collection PubMed
description Blood transfusion in Poland is the safest in history. High virological level of safety has been achieved mainly by improving not only the qualification of donors and methods used for donor screening, but also applying leukoreduction, pathogen reduction technology and grace period for serum. In this article, we discuss the improvement of the epidemic situation among blood donors for hepatitis B virus (HBV) and hepatitis C virus (HCV) and the increasing trend for HIV. Preliminary results of residual risk calculation for these pathogens are presented. Hepatitis E virus (HEV) and Babesia microti were considered as new factors potentially relevant for the safety of blood transfusion in our country. Due to evidence of West Nile virus (WNV) circulation in the ecosystem in Poland, it is also necessary to monitor the infections with this pathogen. In this article, it was emphasized that the reporting of all possible complications associated with transfusion and meticulous implementation of the look-back procedure play a key role for monitoring the risk of transmission of infectious agents by blood. It is especially important in view of the increasing epidemiological problems associated with emerging infectious agents.
format Online
Article
Text
id pubmed-7094117
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Polskie Towarzystwo Hematologów i Transfuzjologów, Instytut Hematologii i Transfuzjologii. Published by Elsevier Sp. z o.o.
record_format MEDLINE/PubMed
spelling pubmed-70941172020-03-25 Ryzyko przeniesienia czynników zakaźnych przez transfuzje w Polsce Grabarczyk, Piotr Kopacz, Aneta Sulkowska, Ewa Kalińska, Aleksandra Acta Haematol Pol Praca poglądowa/Review Blood transfusion in Poland is the safest in history. High virological level of safety has been achieved mainly by improving not only the qualification of donors and methods used for donor screening, but also applying leukoreduction, pathogen reduction technology and grace period for serum. In this article, we discuss the improvement of the epidemic situation among blood donors for hepatitis B virus (HBV) and hepatitis C virus (HCV) and the increasing trend for HIV. Preliminary results of residual risk calculation for these pathogens are presented. Hepatitis E virus (HEV) and Babesia microti were considered as new factors potentially relevant for the safety of blood transfusion in our country. Due to evidence of West Nile virus (WNV) circulation in the ecosystem in Poland, it is also necessary to monitor the infections with this pathogen. In this article, it was emphasized that the reporting of all possible complications associated with transfusion and meticulous implementation of the look-back procedure play a key role for monitoring the risk of transmission of infectious agents by blood. It is especially important in view of the increasing epidemiological problems associated with emerging infectious agents. Polskie Towarzystwo Hematologów i Transfuzjologów, Instytut Hematologii i Transfuzjologii. Published by Elsevier Sp. z o.o. 2017 2017-07-24 /pmc/articles/PMC7094117/ /pubmed/32226060 http://dx.doi.org/10.1016/j.achaem.2017.07.006 Text en © 2017 Polskie Towarzystwo Hematologów i Transfuzjologów, Instytut Hematologii i Transfuzjologii. Published by Elsevier Sp. z o.o. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Praca poglądowa/Review
Grabarczyk, Piotr
Kopacz, Aneta
Sulkowska, Ewa
Kalińska, Aleksandra
Ryzyko przeniesienia czynników zakaźnych przez transfuzje w Polsce
title Ryzyko przeniesienia czynników zakaźnych przez transfuzje w Polsce
title_full Ryzyko przeniesienia czynników zakaźnych przez transfuzje w Polsce
title_fullStr Ryzyko przeniesienia czynników zakaźnych przez transfuzje w Polsce
title_full_unstemmed Ryzyko przeniesienia czynników zakaźnych przez transfuzje w Polsce
title_short Ryzyko przeniesienia czynników zakaźnych przez transfuzje w Polsce
title_sort ryzyko przeniesienia czynników zakaźnych przez transfuzje w polsce
topic Praca poglądowa/Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094117/
https://www.ncbi.nlm.nih.gov/pubmed/32226060
http://dx.doi.org/10.1016/j.achaem.2017.07.006
work_keys_str_mv AT grabarczykpiotr ryzykoprzeniesieniaczynnikowzakaznychprzeztransfuzjewpolsce
AT kopaczaneta ryzykoprzeniesieniaczynnikowzakaznychprzeztransfuzjewpolsce
AT sulkowskaewa ryzykoprzeniesieniaczynnikowzakaznychprzeztransfuzjewpolsce
AT kalinskaaleksandra ryzykoprzeniesieniaczynnikowzakaznychprzeztransfuzjewpolsce